When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 11 Hits
  • Search Condition : Filter (MeSH = Carcinoma, Hepatocellular / therapy*)
Species Resource Title
Human and Animal Cells Li-7(RCB1941) , HuH-7(RCB1366) RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.
Human and Animal Cells HuH-7 Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma.
Human and Animal Cells Vero(RCB0001) Third-generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice.
Human and Animal Cells HuH-7 Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.
Human and Animal Cells HuCCT1(RCB1960) Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.
Human and Animal Cells Hep G2(RCB1648) Enzymatically prepared redox-responsive hydrogels as potent matrices for hepatocellular carcinoma cell spheroid formation.
Human and Animal Cells K562(RCB0027) , HFWT(RCB0665) , HMV-II(RCB0777) Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma.
Human and Animal Cells Autologous fixed tumor vaccine: a formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma.
Human and Animal Cells HuH-7(RCB1366) , HuH-6(RCB1367) Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
Human and Animal Cells RCN-9(RCB0511) Adenovirus-mediated CD40L gene therapy induced both humoral and cellular immunity against rat model of hepatocellular carcinoma.
DNA material pCMV (Hu beta) (RDB01681) , pCAZ 2 (RDB01870). Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents.